Subversion of cytokine networks by viruses

International Reviews of Immunology

Volumn 17, Issue 1-4, 1998, Pages 121-155

  Wall, Erika M ^a   Cao, Jing Xin ^a,b   Upton, Chris ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cytokine network; Cytokine receptor; Immune regulation; Interferon; Viral pathogenesis

Indexed keywords

EID: 0032411330     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189809084490     Document Type: Article

References (200)

1. Theze, J. Cytokine receptors: A combinative family of molecules. Eur. Cytokine. Netw. 5, 353-368, 1994.
2. Vilcek, J. and Sen, G.C. Interferons and other cytokines. In: Fundamental Virology 3rd 1996, edited by Fields, B.N., Knipe, D.M. and Howley, P.M. Philadelphia: Lippincott-Raven Publishers, pp. 341-365.
3. Kroemer, G., Dealboran, I.M., Gonzalo, J.A. and Martinez, C. Immunoregulation by cytokines. Crit. Rev. Immunol. 13, 163-191, 1993.
4. Balkwill, F.R. and Burke, F. The cytokine network. Immunol. Today 10, 299-304, 1989.
5. Lidbury, B.A. Was exposure to directly antiviral cytokines during primary infection an important selective pressure in the evolution of unique immune evasion strategies by viruses? Immun. Cell Biol. 72, 347-350, 1994.
6. Moss, B. Poxviridae: The viruses and their replication. In: Fundamental Virology 3rd 1996, edited by Fields, B.N., Knipe, D.M. and Howley, P.M. Philadelphia: Lippincott-Raven Publishers, pp. 1163-1197.
7. Perkus, M.E., Goebel, S.J., Davis, S.W., Johnson, G.P., Norton, E.K. and Paoletti, E. Deletion of 55 open reading frames from the termini of vaccinia virus. Virol. 180, 406-410, 1991.
8. Smith, G.L. Vaccinia virus glycoproteins and immune evasion. J. Gen. Virol. 74, 1725-1740, 1993.
9. Alcami, A. and Smith, G L. Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol. Today 16, 474-478, 1995.
10. McFadden, G., Graham, K., Ellison, K., Barry, M., Macen, J., Schreiber, M., Mossman, K., Nash, P., Lalani, A. and Everett, H. Interruption of cytokine networks by poxviruses: Lessons from myxoma virus. J. Leukocyte Biol. 57, 731-738, 1995.
11. Pickup, D.J. Poxviral modifiers of cytokine responses to infection. Infect. Agent. Dis. 3, 116-127, 1994.
12. Spriggs, M.K. One step ahead of the game: Viral immunomodulatory molecules. Annu. Rev. Immunol. 14, 101-130, 1996.
13. Dinarello, C.A. The biological properties of interleukin-1. Eur. Cytokine. Netw. 5, 517-531, 1994.
14. Black, R.A., Kronheim, S.R. and Sleath, P.R. Activation of interleukin-1 beta by a co-induced protease. FEBS Lett 247, 386-390, 1989
15. Kostura, M.J., Tocci, M.J., Limjuco, G., Chin, J., Cameron, P., Hillman, A.G., Chartrain, N.A. and Schmidt, J.A. Identification of a monocyte specific preinterleukin 1 beta convertase activity. Proc. Natl. Acad. Sci. USA 86, 5227-5231, 1989.
16. Pickup, D.J., Ink, B.S., Hu, W., Ray, C.A. and Joklik, W.K. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc. Natl. Acad. Sci. USA 83, 7698-7702, 1986.
17. Palumbo, G.J., Pickup, D.J., Fredrickson, T.N., McIntyre, L.J. and Buller, R.M.L. Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virol. 172, 262-273, 1989.
18. Archard, L.C., Mackett, M., Barnes, D.E. and Dumbell, K R. The genome structure of cowpox virus white pock variants. J. Gen. Virol. 65, 875-886, 1984.
19. Pickup, D.J., Ink, B.S., Parsons, B.L., Hu, W. and Joklik, W.K. Spontaneous deletions and duplications of sequences in the genome of cowpox virus. Proc. Natl. Acad Sci USA 81, 6817-6821, 1984.
20. Fredrickson, T.N , Sechler, J.M., Palumbo, G.J., Albert, J., Khairallah, L.H. and Buller, R.M. Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo Virol. 187, 693-704, 1992.
21. Dinarello, C.A. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J. Infect. Dis. 163, 1177-1184, 1991
22. Rock, L.R., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D. and Goldberg, A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771, 1994.
23. Spies, T. and DeMars, R. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351, 323-324, 1991.
24. Yewdell, J.W. and Bennink, J.R. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52, 1-123, 1992.
25. Boshkov, L.K., Macen, J.L. and McFadden, G. Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus. J. Immunol. 148, 881-887, 1992.
26. Coupar, B.E.H., Andrew, M.E., Both, G.W. and Boyle, D.B. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Eur. J. Immunol. 16, 1479-1487, 1986.
27. Graham, K.A., Opgenorth, A., Upton, C. and McFadden, G. Myxoma virus M11L ORF encodes a protein for which cell surface localization is critical in manifestation of viral virulence. Virol. 191, 112-124, 1992.
28. Opgenorth, A., Graham, K., Nation, N., Strayer, D. and McFadden, G. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 66, 4720-4731, 1992.
29. Macen, J.L., Graham, K.A., Lee, S.F., Schreiber, M., Boshkov, L.K. and McFadden, G. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virol. 218, 232-237, 1996.
30. Upton, C., DeLange, A.M. and McFadden, G. Tumorigenic poxviruses: genomic organization and DNA sequence of the telomeric region of the Shope fibroma virus genome. Virol. 160, 20-30, 1987
31. Smith, C.A., Davis, T., Anderson, D., Solam, L., Beckmann, M.P., Jerzy, R., Dower, S K., Cosman, D and Goodwin, R.G. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019-1023, 1990.
32. Smith, C.A., Davis, T., Wignall, J.M., Din, W.S , Farrah, T., Upton, C., McFadden, G. and Goodwin, R G. T2 open reading frame from the shope fibroma virus encodes a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 176, 335-342, 1991.
33. Beyaert, R. and Fiers, W. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity-what we do understand and what we do not FEBS Lett. 340, 9-16, 1994.
34. Ruddle, N.H., Millet, I., Picarella, D.D., Kratz, A., Li, C. et al. TNF-alpha (Cachectin) and TNF-beta (Lymphotoxin) - 25 Years of Progress In: Tumor necrosis factor: Molecular and cellular biology and clinical relevance 1993, edited by Fiers, W. and Buurman, W. A. Basel Karger, pp. 1-9.
35. Tartaglia, L.A., Weber, R.F., Figari, I.S., Reynolds, C., Palladino, M.A. Jr. and Goeddel, D.V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88, 9292-9296, 1991.
36. Upton, C., Macen, J.L., Schreiber, M. and McFadden, G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virol. 184, 370-382, 1991.
37. Schreiber, M., Sedger, L. and McFadden, G. Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. J. Virol. 71, 2171-2181, 1997.
38. Hu, F.Q., Smith, C.A. and Pickup, D.J. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virol. 204, 343-356, 1994.
39. Shchelkunov, S.N., Blinov, V.M. and Sandakhchiev, L.S. Genes of Variola and Vaccinia Viruses Necessary to Overcome the Host Protective Mechanisms. FEBS Lett. 319, 80-83, 1993.
40. Massung, R.F., Esposito, J.J., Liu, L., Qi, J., Utterback, T,R., Knight, J.C., Aubin, L., Yuran, T.E., Parsons, J.M., Loparev, V.N , Selivanov, N.A., Cavallaro, K.F., Kerlavage, A.R., Mahy, B.W. and Venter, J.C. Potential virulence determinants in terminal regions of variola smallpox virus genome. Nature 366, 748-751, 1993.
41. Smith, G.L. and Chan, Y.S. Two vaccinia proteins structurally related to the interleukin-1 receptor and the immunoglobulin super family. J. Gen. Virol. 72, 511-518, 1991.
42. Alcami, A. and Smith, G.L. A soluble receptor for interleukin-1β encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection. Cell 71, 153-167, 1992.
43. Spriggs, M.K., Hruby, D.E., Malizewski, C R., Pickup, D.J., Sims, J.E., Buller, R.M.L. and VanSlyke, J. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71, 145-152, 1992.
44. Isaacs, A. and Lindenmann, J. The Interferons. Proc. R. Soc. Lon. 147, 258-267, 1957
45. Wargnier, A. and Lagrange, P.H. Bactericidal Activity of the Cellular Immune System. Pathol. Biol. 41, 887-896, 1993.
46. Upton, C., Mossman, K. and McFadden, G. Encoding of a homolog of the IFN-gamma receptor by myxoma virus. Science 258, 1369-1373, 1992.
47. Mossman, K., Nation, P , Macen, J., Garbutt, M., Lucas, A. and McFadden, G. Myxoma virus M-T7, a secreted homolog of the interferon-γ receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virol. 215, 17-30, 1996.
48. Colamonici, O.R., Domanski, P., Sweitzer, S.M., Lamer, A. and Buller, R.M. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha signaling. J. Biol Chem. 270, 15974-15978, 1995.
49. Symons, J.A., Alcami, A and Smith, G.L. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81, 551-560, 1995.
50. Ueda, Y., Morikawa, S. and Matsuura, Y. Identification and nucleotide sequence of the gene encoding a surface antigen induced by vaccinia virus, Virol. 177, 588-594, 1990
51. Schall, T.J. and Bacon, K.B. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6, 865-873, 1994
52. Ahuja, S.K., Gao, J.L. and Murphy, P.M. Chemokine receptors and molecular mimicry. Immunol. Today 15, 281-287, 1994.
53. Murphy, P.M. Molecular piracy of chemokine receptors by herpesviruses. Infect. Agent. Dis. 3, 137-154, 1994.
54. Horuk, R. Molecular properties of the chemokine receptor family. Trends. Pharmacol. Sci. 15, 159-165, 1994.
55. Murphy, P.M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12, 593-633, 1994.
56. Graham, K.A., Lalani, A.S., Macen, J.L., Ness, T.L., Barry, M., Liu, L.Y., Lucas, A., Clark-Lewis, I., Moyer, R.W. and McFadden, G. The T1/35 kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virol. 229, 12-24, 1997.
57. Massung, R.F., Jayarama, V. and Moyer, R.W. DNA sequence analysis of conserved and unique regions of swinepox virus: Identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virol. 197, 511-528, 1993.
58. Cao, J.X., Gershon, P.D. and Black, D.N. Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue. Virol. 209, 207-212, 1995.
59. McKenzie, R., Kotwal, G.J., Moss, B., Hammer, C.H. and Frank, M.M. Regulation of Complement Activity by Vaccinia Virus Complement-Control Protein. J. Infect. Dis. 166, 1245-1250, 1992.
60. Isaacs, S.N., Kotwal, G.J. and Moss, B. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA 89, 628-632, 1992.
61. Staeheli, P. Interferon-induced proteins and the antiviral state. Adv. Virus. Res. 38, 147-199, 1990.
62. Hershey, J.W.B. Translational control in mammalian cells. Ann. Rev. Biochem. 60, 717-755, 1991.
63. Thaeore, H.R. and Youngner, J.S. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. I. Rescue in cell culture from different species. Virol. 56, 505-511, 1973.
64. Thaeore, H.R. and Youngner, J.S. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors. Virol. 56, 512-522, 1973.
65. Paez, E. and Esteban, M. Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virol. 134, 12-28, 1984.
66. Chang, H. W., Watson, J.C. and Jacobs, B.L. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced double stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 89, 4825-4829, 1992.
67. Beattie, E., Tartaglia. J. and Paoletti, E. Vaccinia virus-encoded e1F-2α homolog abrogates the antiviral effect of interferon. Virol. 183, 419-422, 1991
68. Davies, M.V., Elroy-Stein, O., Jagus, R., Moss, B. and Kaufman, R.J. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66, 1943-1950, 1992.
69. Carroll, K., Elroystein, O., Moss, B and Jagus, R. Recombinant Vaccinia Virus K3L Gene Product Prevents Activation of Double-Stranded RNA-Dependent, Initiation Factor-2-alpha-Specific Protein Kinase. J. Biol. Chem. 268, 12837-12842, 1993.
70. Stroobant, P., Rice, A.P., Gullick, W.J., Cheng, D.J., Kerr, I.M. and Waterfield, M.D Purification and characterization of vaccinia virus growth factor. Cell 42, 383-393, 1985
71. Twardzik, D.R , Brown, J.B., Ranchalis, J.E., Todaro, G.J. and Moss, B. Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors. Proc. Natl. Acad. Sci. USA 82, 5300-5304, 1985.
72. King, C.S., Cooper, J.A., Moss, B and Twardzik, D.R. Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors. Mol. Cell. Biol. 6, 332-336, 1986.
73. Lyttle, D.L., Fraser, K.M., Fleming, S.B., Mercer, A.A. and Robinson, A.J. Homologs of vascular endothelial growth factor are encoded by the poxvirus ORF virus. J Virol. 68, 84-92, 1994
74. Upton, C., Macen, J L., Wishart, D.S. and McFadden, G. Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virol. 179, 618-631, 1990.
75. Lomas, D.A., Evans, D.L., Upton, C., McFadden, G. and Carrell, R.W. Inhibition of Plasmin, Urokinase, Tissue Plasminogen Activator, and C1S by a Myxoma Virus Serine Proteinase Inhibitor. J. Biol. Chem. 268, 516-521, 1993.
76. Macen, J.L., Upton, C., Nation, N. and McFadden, G. SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation Virol. 195, 348-363, 1993.
77. Shenk, T. Adenoviridae: The viruses and their replication. In: Fundamental Virology 3rd 1996, edited by Fields, B.N., Knipe, D.M. and Howley, P.M. Philidelphia: Lippincott-Raven Publishers, pp. 979-1016.
78. Trentin, J.J., Yabe, Y and Taylor, G. The quest for human cancer viruses. Science 137, 835-849, 1962
79. Wold, W.S.M., Hermiston, T W. and Tollefson, A.E. Adenovirus proteins that subvert host defenses. Trends. Micro. 2, 437-443, 1994.
80. Rotem-Yehudar, R., Groettrup, M., Soza, A., Kloetzel, P.M. and Ehrlich, R. LMP-associated proteolytic activities and TAP-dependent peptide transport for class I MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. J. Exp. Med. 183, 499-514, 1996.
81. Aki, M., Shimbara, N., Takashina, M., Akiyama, K., Kagawa, S., Tamura, T., Tanahashi, N., Yoshimura, T., Tanaka, K. and Ichihara, A. Interferon-gamma Induces Different Subunit Organizations and Functional Diversity of Proteasomes. J. Biochem. Tokyo 115, 257-269, 1994.
82. Rotem-Yehudar, R., Winograd, S., Sela, S., Coligan, J.E. and Ehrlich, R. Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12. J. Exp Med. 180, 477-488, 1994.
83. Schouten, G.J., van der Eb, A.J. and Zantema, A. Downregulation of MHC class I expression due to interference with p105-NF kappa B1 processing by Ad12E1A. EMBO J. 14, 1498-1507, 1995.
84. Pestka, S , Langer, J.A., Zoon, K.C. and Samuel, C.E. Interferons and their actions. Ann Rev. Biochem. 56, 727-777, 1987.
85. Paabo, S., Severinsson, L., Andersson, M., Martens, I., Nilsson, T. and Peterson, P.A. Adenovirus proteins and MHC expression. Adv. Cancer. Res. 52, 151-163, 1989.
86. Gooding, L.R. and Wold, W.S.M. Molecular mechanisms by which adenoviruses counteract antiviral immune defenses. CRC Crit. Rev. Immunol. 10, 53-71, 1989.
87. Burgert, H -G. and Kvist, S. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens Cell 41, 987-997, 1985.
88. Janaswami, P M., Kalvakolanu, D.V.R., Zhang, Y. and Sen, G.C. Transcriptional repression of interleukin-6 gene by adenoviral E1A proteins. J. Biol. Chem. 267, 24886-24891, 1992.
89. Akira, S., Taga, T. and Kishimoto, T. Interleukin 6 in biology and medicine. Adv. Immunol. 54, I -48, 1993.
90. Fattori, E M., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M , Faggioni, R , Fantuzzi, G , Ghezzi, P. and Poli, V. Defective inflammatory response in interleukin 6-deficient mice. J Exp. Med. 180, 1243-1250, 1994
91. Wong, G.H.W and Goedell, D.V. Tumor necrosis factor a and 3 inhibit virus replication and synergize with interferons. Nature 323, 819-822, 1986.
92. Kirstein, M. and Baglioni, C. Tumor necrosis factor induces synthesis of two proteins in human fibroblasts. J. Biol. Chem. 261, 9565-9567, 1986.
93. Ames, R S , Holskin, B., Mitcho, M., Shalloway, D. and Chen, M.-J. Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation. J. Virol. 64, 4115-4122, 1990.
94. Duerksen-Hughes, P.J., Hermiston, T.W , Wold, W.S.M. and Gooding, L.R. The amino-terminal portion of CD1 of the adenovirus E1A proteins is required to induce susceptibility to tumor necrosis factor cytolysis in adenovirus-infected mouse cells. J Virol 65, 1236-1244, 1991.
95. Bandara, L.R. and La Thangue, N.B. Adenovirus E1A prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351, 494-497, 1991.
96. Hollingworth, R.E., Chen, P.-L. and Lee, W.-H. Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein. Curr. Opin. Cell Biol. 5, 194-200, 1993.
97. Moran, E. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3, 63-70, 1993.
98. Shisler, J., Duerksen-Hughes, P., Hermiston, T.M., Wold, W.S.M. and Gooding, L.R. Induction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis. J. Virol. 70, 68-77, 1996.
99. Gooding, L.R., Elmore, L.W., Tollefson, A.E., Brady, H.A. and Wold, W.S.M. A 14,700 MW protein from the E3 region of Adenovirus inhibits cytolysis by tumor necrosis factor. Cell 53, 341-346, 1988.
100. Gooding, L.R., Ranheim, T.S., Tollefson, A.E., Aquino, L., Duerksen-Hughes, P., Horton, T.M. and Wold, W.S.M. The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus function together to protect many but not all mouse cell lines against lysis by tumor necrosis factor. J. Virol. 65, 4114-4123, 1991.
101. Tufariello, J., Cho, S. and Horwitz, M.S. The adenovirus E3 14.7-kilodalton protein which inhibits cytolysis by tumor necrosis factor increases the virulence of vaccinia virus in a murine pneumonia model. J. Virol. 68, 453-462, 1994.
102. 2 activity, but not with arachidonic acid release per se. Eur. J. Biochem. 195, 465-475, 1991.
103. 2. Semin. Virol. 5, 431-442, 1994.
104. Sparer, T.E., Tripp, R.A., Dillehay, D.L., Hermiston, T.W., Wold, W.S.M. and Gooding, L.R. The role of human adenovirus early region 3 proteins (gp19K, 10.4 K, 14.5 K, and 14.7 K) in a murine pneumonia model. J. Virol. 70, 2431-2439, 1996.
105. Baumann, H. and Gauldie, J. The acute phase response. Immunol. Today 15, 74-80, 1994.
106. Schutze-Osthoff, K., Bakker, A.C., Vanhaesebroeck, B., Beyaert, R., Jacob, W.A. and Fiers, W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. Biol. Chem. 267, 5317-5323, 1992.
107. Lancaster, J.R. Jr., Laster, S.M. and Gooding, L.R Inhibition of target cell mitochondrial electron transfer by tumor necrosis factor. FEBS Lett. 248, 169-174, 1989.
108. Ginsberg, H.S., Lundholm-Beauchamp, U., Horswood, R.L., Pernis, B., Wold, W.S.M., Chanock, R.M. and Prince, G.A. Role of early region 3 (E3) in pathogenesis of adenovirus disease Proc. Natl. Acad Sci USA 86, 3823-3827, 1989.
109. Rao, L., Debbas, M., Sabbatini, P., Hockenbery, S., Korsmeyer, S. and White, E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2. Proc. Natl. Acad. Sci. USA 89, 7742-7746, 1992.
110. Boyd, J.M., Malstrom, S., Subramanian, T., Venkatesh, L.K., Schaeper, U., Elangovan, B., D'Sa-Eipper, C. and Chinnadurai, G. Adenovirus E1B 19kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79, 341-351, 1994
111. Levy, D.E., Kessler, D.S., Pine, R. and Darnell, J.E. Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev. 3, 1362-1371, 1989.
112. Levy, D.E., Kessler, D.S., Pine, R., Reich, N. and Darnell, J.E. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev. 2, 383-393, 1988.
113. Ackrill, A M., Foster, G.R., Laxton, C.D., Flavell, D.M., Stark, G.R. and Kerr, I M. Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res. 19, 4387-4393, 1991.
114. Kalvakolanu, D.V.R., Bandyopadhyay, S-K., Harter, M.L. and Sen, G.C. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: Block in transcriptional complex formation. Proc. Natl. Acad. Sci. USA 88, 7459-7463, 1991.
115. Gutch, M.J. and Reich, N.C Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. USA 88, 7913-7917, 1991.
116. Routes, J.M., Li, H., Bayley, S.T., Ryan, S. and Klemm, D.J. Inhibition of IFN-stimulated gene expression and IFN induction of cytolytic resistance to natural killer cell lysis correlate with E1A-p300 binding. J. Immunol. 156, 1055-1061, 1996.
117. Routes, J.M. Adenovirus E1A inhibits IFN-induced resistance to cytolysis by natural killer cells. J Immunol. 150, 4315-4322, 1993.
118. Ghadge, G.D., Swaminathan, S., Katze, M.G. and Thimmapaya, B. Binding of the adenovirus VAI RNA to the interferon-induced 68-kDa protein kinase correlates with function. Proc. Natl. Acad. Sci. USA 88, 7140-7144, 1991.
119. Mathews, M.B. and Shenk, T. Adenovirus virus-associated RNA and translation control. J. Virol. 65, 5657-5662, 1991.
120. Pe'ery, T., Mellits, K.H. and Mathews, M.B. Mutational analysis of the central domain of adenovirus virus-associated RNA mandates a revision of the proposed secondary structure. J. Virol. 67, 3534-3543, 1993.
121. f protein kinase to regulate its autophosphorylation and activity. EMBO J. 6, 689-697, 1987.
122. Green, S.R. and Mathews, M.B. Two RNA binding motifs in the double-stranded RNA activated protein kinase, DAI. Genes Dev. 6, 2478-2490, 1992.
123. Thimmappaya, B., Weinberger, C., Schneider, R.J. and Shenk, T. Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31, 543-551, 1982.
124. Desai, S.Y., Patel, R.C., Sen, G.C., Malhotra, P., Ghadge, G.D. and Thimmapaya, B. Activation of interferon-inducible 2′-5′ oligoadenylate synthetase by adenoviral VA1 RNA. J. Biol. Chem. 270, 3454-3461, 1995.
125. Roizman, B. Herpesviridae: A brief introduction. In: Fields Virology 2nd 1990, edited by Fields, B. N. and Knipe, D. M. New York: Raven Press, Ltd., pp. 1787-1794.
126. Fruh, K., Ahn, K , Kjaballah, H., Sempe, P., van Endert, P.M., Tampe, R., Peterson, P.A and Yang, Y. A viral inhibitor of peptide transporters for antigen presentation. Nature 5, 415-418, 1995.
127. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H. and Johnson, D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 5, 411-415, 1995.
128. Alford, C.A. and Britt, W.J. Cytomegalovirus. In: Fields Virology 2nd 1990, edited by Fields, B. N. and Knipe, D. M. New York: Raven Press, Ltd., pp. 1981-2010.
129. Jones, T R. and Muzithras, V.P Fine mapping of transcripts expressed from the US6 gene family of human cytomegalovirus strain AD169. J Virol. 65, 2024-2036, 1991.
130. Jones, T.R., Hanson, L.K., Sun, L., Slater, J.S., Stenberg, R M. and Campbell, A.E. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69, 4830-4841, 1995.
131. Neote, K., DiGregorio, D., Mak, J.Y., Horuk, R. and Schall, T.J. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72, 415-425, 1993.
132. Schall, T.J., Stein, B., Gorgone, G. and Bacon, K.B. Cytomegalovirus encodes a functional receptor for C-C chemokines. In: Viroceptors, virokines and related immune modulators encoded by DNA viruses 1995, edited by McFadden, G. Austin: R.G. Landes Company, pp. 201-214.
133. Chee, M.S., Satchwell, S.C., Preddie, E., Weston, K.M. and Barrell, B.G. Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature 344, 774-777, 1990.
134. Nicholas, J., Cameron, K.R. and Honess, K.W. Herpes virus saimiri encodes homologs of G-protein coupled receptors and cyclins. Nature 355, 362-365, 1992.
135. Ahuja, S.K. and Murphy, P.M. Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri. J. Biol. Chem. 268, 20691-20694, 1993.
136. York, I.A. and Johnson, D.C. Inhibition of humoral and cellular immune recognition by herpes simplex viruses. In: Viroceptors, virokines and related immune modulators encoded by DNA viruses 1995, edited by McFadden, G. Austin: R.G. Landes Company, pp. 89-110.
137. Herold, B.C., WuDunn, D., Soltys, N. and Spear, P.G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol 65, 1090-1098, 1991.
138. Harris, S.L., Frank, I., Yee, A., Cohen, G.H., Eisenberg, R.J. and Friedman, H.M. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J. Infect. Dis. 162, 331-337, 1990.
139. Frank, I. and Friedman, H.M. A novel function of the herpes simplex virus type 1 Fc receptor: Participation in bipolar bridging of antiviral immunoglobulin G. J. Virol. 63, 4479-4488, 1989.
140. Albrecht, J.C. and Fleckenstein, B. Complement regulatory proteins of Herpesvirus Saimiri. In: Viroceptors, virokines and related immune modulators encoded by DNA viruses 1995, edited by McFadden, G. Austin: R.G. Landes Company, pp, 127-146.
141. Albrecht, J C. and Fleckenstein, B. New member of the multigene family of complement control proteins in herpesvirus saimiri J. Virol. 66, 3937-3940, 1992.
142. Fodor, W.L , Rollins, S.A., Bianco-Caron, S., Rother, R.P., Guilmette, E.R , Burton, W.V., Albrecht, J.C., Fleckenstein, B. and Squinto, S.P. The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J. Virol. 69, 3889-3892, 1995.
143. Venneker, G.T. and Asghar, S.S. CD59 a molecule involved in antigen presentation as well as downregulation of membrane attack complex. Exp. Clin. Immunogenet. 9, 33-47, 1992.
144. Rother, R.P., Rollins, S.A., Fodor, W.L., Albrecht, J.C., Setter, E., Fleckenstein, B. and Squinto, S P. Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J. Virol. 68, 730-737, 1994.
145. Miller, G. Epstein-barr virus. In: Fields Virology 2nd 1990, edited by Fields, B. N. and Kmpe, D. M. New York: Raven Press, Ltd., pp 1921-1958.
146. Swaminathan, S. and Kieff, E. The role of BCRF1/vIL-10 in the life cycle of Epstein-barr virus. In: Viroceptors, virokines and related immune modulators encoded by DNA viruses 1995, edited by McFadden, G. Austin: R.G. Landes Company, pp. 111-126.
147. 1 clones. J. Exp. Med 170, 2081-2095, 1989.
148. Howard, M. and O'Garra, H. Biological properties of interleukin-10. Immunol. Today 13, 198-200, 1992.
149. Moor, K.W., O'Garra, H., de Waal-Maletyt, R , Vieira, P. and Mosmann, T.R. Interleukin-10. Ann Rev. Immunol. 11, 185-190, 1993.
150. Hudson, G.S., Bankier, A.T., Satchwell, S.C. and Barrell, B.G. The short unique region of the B95-8 Epstein-Barr virus genome. Virol. 147, 81-98, 1985.
151. Stuart, A.D., Stewart, J.P., Arrand, J.R and Mackett, M. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes. Oncogene 11, 1711-1719, 1995.
152. Miyazaki, I., Cheung, R.K. and Dosch, H.M. The role of vIL-10 and other EBV latency genes early during B cell growth transformation. Semin Virol. 5, 405-414, 1994.
153. Rode, H.J., Janssen, W. and Rosen-Woltt, P The genome of equine herpes virus type 2 harbors an IL-10-like gene Virus Genes 7, 111-116, 1993.
154. Yao, Z., Fanslow, W C., Seldin, M.F., Rousseau, A.M., Painter, S.L., Comeau, M R., Cohen, J.I. and Spriggs, M.K. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 3, 811-821, 1995.
155. Rouvier, E., Luciani, M.F., Mattei, M.G., Denizot, F. and Golstein, P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus Saimiri gene. J. Immunol. 150, 5445-5456, 1993.
156. Yao, Z., Painter, S.L., Fanslow, W.C., Ulrich, D., Macduff, B.M., Spriggs, M.K. and Armitage, R.J. Human IL-17: A novel cytokine derived from T cells. J. Immunol. 155, 5483-5486, 1995.
157. Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J.J., Garrone, P., Garcia, E., Saeland, S., Blanchard, D., Gaillard, C., Das Mahapatra, B., Rouvier, E., Golstein, P., Banchereau, J. and Lebecque, S. T cell interleukin-17 induces small stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593-2603, 1996.
158. Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M. and Moore, P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869, 1994.
159. Moore, P.S., Gao, S.J., Dominguez, G., Cesarman, E , Lungu, O , Knowles, D.M., Garber, R., Pellett, P.E., McGeoch, D.J. and Chang, Y. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J. Virol. 70, 549-558, 1996.
160. Neipel, F., Albrecht, J.C., Ensser, A., Huang, Y.Q., Li, J.J., Friedman-Kien, A. E. and Fleckenstein, B Human herpesvirus 8 encodes a homolog of interleukin-6. J. Virol. 71, 839-842, 1997.
161. Ehlers, M., Grotzinger, J., de Hon, F.D., Mullberg, J., Brakenhoff, J.P., Wollmer, A, and Rose John, S Residues 77-95 of the human interleukin-6 protein are responsible for receptor binding and residues 41-56 for signal transduction. Ann. N. Y. Acad. Sci 762, 400-402, 1995.
162. van Dam, M., Mullberg, J., Schooltink, H., Stoyan, T., Brakenhoff, J.P., Graeve, L., Heinrich, P.C. and Rose John, S. Structure-function analysis of interleukin-6 utilizing human murine chimeric molecules. Involvement of two separate domains in receptor binding. J. Biol. Chem. 268, 15285-15290, 1993.
163. Mesri, E.A., Cesarman, E., Arvanitakis, L., Rafii, S., Moore, M.A., Posnett, D.N., Knowles, D.M. and Asch, A.S. Human hervesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells J. Exp. Med. 183, 2385-2390, 1996
164. Miles, S A., Rezai, A.R., Salazar Gonzalez, J.F., Vander Meyden, M., Stevens, R.H., Logan, D.M., Mitsuyasu, R T., Taga, T., Hirano, T., Kishimoto, T and Martinez-Maza, O. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin-6 Proc. Natl. Acad. Sci. USA 87, 4068-4072, 1990.
165. Brandt, S.J., Bodine, D.M., Dunbar, C E. and Nienhuis, A.W. Dysregulated interleukin-6 expression produces a syndrome resembling Castleman's disease in mice. J. Clin. Invest. 86, 592-599, 1990.
166. Tanner, J., Weis, J., Fearon, D., Whang, Y. and Kieff, E. Epstein-Barr virus gp350/ 220 binding to the lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50, 203-213, 1987.
167. Tanner, J.E., Alfieri, C., Chatila, T.A. and Diaz-Mitoma, F. Induction of interleukin-6 after stimulation of human B-cell CD21 of Epstein-Barr virus glycoproteins gp350 and gp220. J. Virol. 70, 570-575, 1996.
168. Tosato, G., Tanner, J., Jones, K D., Revel, M. and Pike, S.E. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J. Virol 64, 3033-3041, 1990
169. Tanner, J. and Tosato, G. Impairment of natural killer functions by interleukin-6 increases lymphoblastoid cell tumorigenicity in athymic mice. J. Clin Invest 88, 239-247, 1991.
170. Yoo, Y.D., Chiou, C.-J., Choi, K.S., Yi, Y., Michelson, S., Kim, S., Hayward, G.S. and Kim, S.-J. The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor β1 gene through an Egr-1 binding site. J. Virol. 70, 7062-7070, 1996.
171. Strassmann, G.M., Cole, D. and Newman, W. Regulation of colony-stimulating factor-1 dependent macrophage precursor proliferation by type β transforming growth factor. J. Immunol. 140, 2645-2651, 1988.
172. Fox, F.E., Ford, H.C., Douglas, R., Cherian, S. and Nowell, P.C. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms. Cell Immunol. 150, 45-58, 1993,
173. Massague, J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6, 587-641, 1990.
174. Tsunawaki, S., Sporn, M.B., Ding, A. and Nathan, C. Deactivation of macrophages by transforming growth factor-β. Nature 334, 260-262, 1988.
175. Alcami, J., Paya, C.V., Virelizier, J.L. and Michelson, S. Antagonistic modulation of human cytomegalovirus replication by transforming growth factor β and basic fibroblast growth factor. J. Gen. Virol. 74, 269-274, 1993.
176. Elias, J.A., Lentz, V. and Cummings, P.J. Transforming growth factor-beta regulation of IL-6 production by unstimulated and IL-1 stimulated human fibroblasts. J. Immunol. 146, 3437-3443, 1991.
177. Zhou, D., Chrest, F.J., Adler, W., Munster, A. and Winchurch, R.A. Increased production of TGF-beta and IL-6 by aged spleen cells. Immunol. Lett. 36, 7-12, 1993.
178. Devergne, O., Hummel, M., Koeppen, H., Le Beau, M.M., Nathanson, E.C., Kieff, E. and Birkenbach, M. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 70, 1143-1153, 1996.
179. Wolf, S.F., Temple, P A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz, L., Ferenz, C., Hewick, R M., Kelleher, K., Herrman, S.H., Clark, S.C., Azzoni, L., Chan, S.H., Trinchieri, G. and Perussia, B. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple effects on T and natural killer cells. J. Immunol. 146, 3074-3081, 1991.
180. Trinchieri, G. Interleukin-12 and its role in the generation of THI cells. Immunol. Today 14, 335-338, 1993.
181. Mattner, F., Fischer, S., Guckes, S., Jin, S., Kaulen, H., Schmitt, E., Rude, E. and Germann, T. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23, 2208-2208, 1993.
182. Ling, P., Gately, M.K., Gubler, U , Stern, A.S., Lin, P., Hollfelder, K., Su, C., Pan, Y.C. and Hakimi, J. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biological activity. J. Immunol 154, 116-127, 1995.
183. D'Andrea, A., Aste-Amezaga, M., Valiante, N.M., Ma, X., Kubin, M. and Trinchieri, G. Interleukin-10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048, 1993.
184. Arrand, J.R. and Rymo, L. Characterization of the major Epstein-Barr virusspecific RNA in Burkitt lymphoma-derived cells. J. Virol. 41, 376-389, 1982.
185. Rooney, C., Howe, J.G., Speck, S.H. and Miller, G. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus J. Virol. 63, 1531-1539, 1989.
186. Howe, J.G and Shu, M.D. Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements. Cell 57, 825-834, 1989.
187. Glickman, J.N., Howe, J.G. and Steitz, J.A. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J. Virol. 62, 902-911, 1988.
188. Bhat, R.A. and Thimmappaya, B. Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus J. Virol. 56, 750-756, 1985.
189. Bhat, R.A. and Thimmappaya, B. Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5, Proc. Natl. Acad. Sci. USA 80, 4789-4793, 1983.
190. 1 RNA, Nucleic Acids Res, 21, 4483-4490, 1993.
191. Lamb, R.A. and Kolakofsky, D. Paramyxoviridae: the viruses and their replication. In: Fundamental Virology 3rd 1996, edited by Fields, B. N., Knipe, D. M. and Howley, P M. Philadelphia: Lippincott-Raven Publishers, pp. 577-604.
192. Salmi, A.A. Suppression of T-cell immunity after measles infection: is the puzzle solved? Trends. Micro. 5, 85-86, 1997.
193. Karp, C.L., Wysocka, M., Wahl, L.M., Ahearn, J.M., Cuomo, P.J., Sherry, B., Trinchien, G. and Griffin, D.E. Mechanism of suppression of cell-mediated immunity by measles virus. Science 273, 228-231, 1996.
194. Schultz-Cherry, S. and Hinshaw, V.S. Influenza virus neuraminidase activates latent transforming growth factor β. J. Virol. 70, 8624-8629, 1996.
195. Lamb, R.A. and Krug, R.M. Orthomyxoviridae: The viruses and their replication. In: Fundamental Virology 3rd 1996, edited by Fields, B.N., Knipe, D.M. and Howley, P.M. Philadelphia: Lippincott-Raven Publishers, pp. 605-647.
196. Nibert, M.L., Schiff, L.A. and Fields, B.N. Reoviruses and their replication. In: Fundamental Virology 3rd 1996, edited by Fields, B.N., Knipe, D.M. and Howley, P.M. Philadelphia: Lippincott-Raven Publishers, pp. 691-730.
197. Lloyd, R.M. and Shatkin, A.J. Translational stimulation by reovirus polypeptide σ3: Substitution for VAI RNA and inhibition of phosphorylation of the α subunit of eukaryotic initiation factor 2. J. Virol. 66, 6878-6884, 1992.
198. Beattie, E., Denzler, K.L., Tartaglia, J., Perkus, M.E., Paoletti, E. and Jacobs, B.L. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene. J Virol. 69, 499-505, 1995
199. Senkevich, T.G., Bugert, J.J., Sisler, J.R., Koonin, E.V., Darai, G. and Moss, B. Genome sequence of a human tumorigenic poxvirus: Prediction of specific host response-evasion genes. Science 273, 813-816, 1996.
200. Porter, C.D. and Archard, L.C Molluscum contagiosum virus. In: Encyclopedia of Virology 1994, edited by Webster, R.G and Granoff, A. San Diego: Academic Press, pp. 848-853